ClinicalThought
View More
Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in the United States, from Clinical Care Options (CCO)
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Jennifer Wild, MS, BSN, RN, OCN
Released: June 22, 2022
Clinical Care Options (CCO) commentary from Dr Carla Coffin on risks vs benefits of treating patients in the indeterminate category for HBV treatment
Carla Coffin, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: June 21, 2022
Expired:
June 20, 2023
Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis
Sherry Tierney
Physicians:
maximum of 0.5 AMA PRA Category 1 Credits™
Registered Nurses:
0.5 Nursing contact hours
Pharmacists:
0.5 contact hours (0.05 CEUs)
Released: May 17, 2022
Expired:
May 16, 2023
Clinical Care Options (CCO) commentary from Maria Buti, MD, on the interplay between HBV infection and pregnancy
Maria Buti, MD
Physicians:
maximum of 0.5 AMA PRA Category 1 Credits™
Registered Nurses:
0.5 Nursing contact hours
Pharmacists:
0.5 contact hours (0.05 CEUs)
Released: April 18, 2022
Expired:
April 17, 2023
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.